Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Shares Outstanding (Diluted Average): 2016-2025

Historic Shares Outstanding (Diluted Average) for Capricor Therapeutics (CAPR) over the last 6 years, with Sep 2025 value amounting to $45.7 million.

  • Capricor Therapeutics' Shares Outstanding (Diluted Average) rose 38.16% to $45.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year increase of 38.16%. This contributed to the annual value of $35.2 million for FY2024, which is 31.52% up from last year.
  • According to the latest figures from Q3 2025, Capricor Therapeutics' Shares Outstanding (Diluted Average) is $45.7 million, which was up 0.02% from $45.7 million recorded in Q2 2025.
  • In the past 5 years, Capricor Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $45.7 million in Q3 2025 and a low of $22.2 million during Q1 2021.
  • In the last 3 years, Capricor Therapeutics' Shares Outstanding (Diluted Average) had a median value of $31.8 million in 2024 and averaged $33.8 million.
  • Data for Capricor Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 52.64% (in 2021) over the last 5 years.
  • Over the past 5 years, Capricor Therapeutics' Shares Outstanding (Diluted Average) (Quarterly) stood at $23.1 million in 2021, then climbed by 6.34% to $24.6 million in 2022, then climbed by 9.06% to $26.8 million in 2023, then soared by 31.52% to $35.2 million in 2024, then soared by 38.16% to $45.7 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $45.7 million in Q3 2025, compared to $45.7 million in Q2 2025 and $45.6 million in Q1 2025.